Close

Amylin Pharmaceuticals, Inc. (AMLN) Posts Q3 Loss of $0.07, Sales Fall Short

October 19, 2011 4:06 PM EDT
Get Alerts AMLN Hot Sheet
Price: $30.98 --0%

Financial Fact:
Total revenues: 153.69M

Today's EPS Names:
FSI, RELV, NEOM, More
Join SI Premium – FREE
Amylin Pharmaceuticals, Inc. (NASDAQ: AMLN) reported Q3 EPS of ($0.07), $0.08 better than the analyst estimate of ($0.15). Revenue for the quarter came in at $155.1 million versus the consensus estimate of $166.39 million.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings